Quantitative Life Sciences
  • Home
  • About
  • Products
    • Predictive Analytics
    • Portfolio Management
  • Publications
  • News
  • Contact
Select Page
BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation

BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation

by Philippe Alexis | Jul 18, 2022 | Uncategorized

Strategies will focus on public and private companies developing potentially life-changing medical treatments Partnership combines the insights and scale of BlackRock’s active investment platform with QLS’s cutting-edge approach to investing in life sciences NEW YORK,...

Recent Posts

  • BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation
  • BIO, QLS, and Informa Pharma Intelligence have released a new report on clinical development success rates covering 2011-2020
  • Informa Pharma Intelligence and QLS Partner to Pilot Predictive Analysis Tool for Clinical Trials

Recent Comments

    Copyright © 2023 QLS Technologies LLC – All Rights Reserved | Privacy Policy | Terms and Conditions